Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:

819 results found

Validation of clinical assays to measure GCase activity in white blood cells for identifying GBA1-associated Parkinson’s Disease

Enzymes are mother nature’s catalysts responsible for the chemistry of metabolic pathways in living cells. In some diseases, the function of an enzyme is deficient which can lead to dysfunction or early cell death.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
2025-2026 Solutions Program Innovation + Impact Grants

Facilitating neuroplasticity: acute intermittent hypoxia in later stages of MS

Multiple Sclerosis (MS) is a disease that affects the brain and spinal cord, leading to a gradual loss of nerve function. Canada—especially Saskatchewan—has the highest rates of MS in the world.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
2025-2026 Solutions Program Innovation + Impact Grants
Province
Saskatchewan

Evaluating community-based exercise and rehabilitation for physical and personal achievement among people living with chronic neurological conditions

Exercise and rehabilitation can help people with neurological conditions to improve physical function even years after a diagnosis. Yet, after hospital discharge, there are few available services for people with neurological conditions.


Grant type
Team grants
Area of Research
Central Nervous System
Competition
2025-2026 Solutions Program Innovation + Impact Grants
Province
Saskatchewan

Optimizing interpersonal light touch instructions to improve standing balance: Examining the impact of different instructions on postural sway and its underlying neural mechanisms

This research explores how lightly touching another person, called interpersonal light touch (IPLT), can help people stay balanced while standing.


Grant type
Team grants
Area of Research
Central Nervous System
Competition
2025-2026 Solutions Program Innovation + Impact Grants
Province
Saskatchewan

Preclinical assessment of a small molecule to treat neurodegeneration and inhibit disability in multiple sclerosis

Canada has one of the highest rates of MS in the world, with treatment costing an estimated $2 billion per year by 2031. Even with modern treatments, persons living with MS accumulate long-term neurological disability over time.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
2025-2026 Solutions Program Innovation + Impact Grants
Province
Saskatchewan

Evaluating an AI-Driven Mental Health App (LifeLine) in Northern Communities: A Randomized Controlled Trial

Many people in northern and Indigenous communities in Saskatchewan face challenges in accessing mental health support due to distance, limited services, and long wait times.


Grant type
Team grants
Area of Research
Mental Health
Competition
2025-2026 Solutions Program Innovation + Impact Grants
Province
Saskatchewan

Customizing HELP (the Health Education and Learning Platform) to Improve Self-Management for People Living with Chronic Pain and FASD

Managing chronic health conditions like chronic pain and Fetal Alcohol Spectrum Disorder (FASD) can be challenging, especially when support is limited. Our team has developed a mobile app called HELP (Health Education and Learning Platform) to support people in managing their health.


Grant type
Team grants
Area of Research
Central Nervous System
Competition
2025-2026 Solutions Program Innovation + Impact Grants
Province
Saskatchewan

Neuromodulation of the posterior hypothalamus as a potential novel therapy for drug-resistant temporal lobe epilepsy

Epilepsy is a severe neurological disorder that affects approximately 300,000 Canadians. Temporal lobe epilepsy is the most common form of epilepsy in adults and is characterized by seizures that cause abnormal sensations, impaired consciousness, and loss of motor control.


Grant type
Team grants
Area of Research
Central Nervous System
Competition
2025-2026 Solutions Program Innovation + Impact Grants
Province
Saskatchewan

Exploring New Therapeutic Approaches for Medulloblastoma

Medulloblastoma (MB) is a brain cancer that affects children.


Area of Research
Cancer
Competition
CRS Doctoral Research Awards
Province
Québec

Mapping and targeting cellular heterogeneity in sonic hedgehog medulloblastoma 

Medulloblastoma isthe most common brain cancer in children.


Area of Research
Cancer
Competition
CRS Doctoral Research Awards
Province
Ontario